Women who underwent autologous breast reconstruction following a mastectomy reported greater psychosocial and sexual well-being than those who chose implant-based reconstruction, according to a study published in the Journal of Clinical Oncology.
Targeting a molecule called B7-H4 may lead to the development of new therapies that boost the immune system’s ability to fight cancer, according to a review published in the journal Immunological Reviews.
Northwestern Medicine scientists have developed a novel testing platform to assess, in real time, the efficacy of nanomaterials in regulating gene expression.
Northwestern medicine scientist have shown how a medical device that delivers alternating electrical fields in addition to traditional chemotherapy can improve survival for patients with glioblastoma.
Scientists have demonstrated that a small-molecule inhibitor can preserve fertility in mice, when administered as a co-treatment with conventional chemotherapy.
A new study defined the architecture of nuclear lamins, the fibrous proteins in a cell’s nucleus, providing further insights into their role in cell structure.
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
In research published in Nature Medicine, Northwestern Medicine scientists have found a molecule that stops the growth of an aggressive pediatric brain tumor for which there is no current treatment.
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
A newly identified biomarker may predict treatment response in patients with chronic myelogenous leukemia, according to a Northwestern Medicine study.